Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Pallor, Pediatric


Basics


Description


  • Pallor is defined as paleness of the skin and may be a reflection of anemia or poor peripheral perfusion.
  • The normal range for hemoglobin is age dependent.
  • Anemia can be defined functionally as the inability of hemoglobin to meet cellular oxygen demand.
  • Parents often fail to notice pallor of gradual onset.
    • Grandparents or others who see the child less often may be the first to suspect pallor.

Risk Factors


  • Ages between 6 months and 3 years or adolescent females
    • Peak age ranges for iron deficiency
  • Gender
    • Some red cell " “enzyme X-linked defects such as glucose-6-phosphate dehydrogenase (G6PD) and phosphoglycerate kinase deficiencies are sex linked.
  • Race
    • African: hemoglobins S and C,α- and Ž ²-thalassemia trait, G6PD deficiency
    • Southeast Asian: hemoglobin E andα-thalassemia
    • Mediterranean descent: Ž ²-thalassemia and G6PD deficiency

Genetics
Familial history: Some of the congenital hemolytic anemias are autosomal dominant. ‚  

Diagnosis


  • Determine first that the child appears pale, not simply fair skinned. Second, decide if there is a medical emergency associated with circulatory failure. If not, the goal is to investigate the etiology and intervene appropriately.
  • Phase 1: Assess for signs of shock.
    • If present, initiate emergency procedures as required to stabilize the patient, such as airway, breathing, and circulation.
  • Phase 2: If patient is stable, perform history, physical examination, and CBC with reticulocyte count to establish time of onset of pallor, associated symptoms, and level of anemia.
  • Phase 3: Follow specific diagnostic workup based on findings in phase 2.

Signs and Symptoms


  • Pallor
  • Other signs and symptoms dependent on etiology

History


  • Acute versus chronic onset
    • Helps with differential diagnosis
  • Associated symptoms: weight loss, fever, night sweats, cough, and/or bone pain
    • Suggest an underlying systemic illness, such as leukemia, infection, or rheumatologic disorder
  • Jaundice, scleral icterus, dark urine
    • Suggest hemolysis
  • Age <6 months
    • May represent a congenital anemia or isoimmunization
  • Premature infant
    • Increased risk of both iron and vitamin E deficiency
    • Exaggerated hyperbilirubinemia can be the presenting symptom of isoimmune hemolytic or other congenital hemolytic anemia.
  • Pica
    • Often associated with plumbism and iron deficiency
  • Medications
    • Can cause bone marrow suppression and/or hemolysis
  • Milk intake
    • Introduction of cow 's milk at <12 months of age is associated with iron deficiency.
    • Drinking a lot of cow 's milk (>24 oz/day) puts a toddler at risk for iron deficiency.
  • Recent trauma and/or surgery
    • Blood loss can result in iron deficiency.
  • Recent infection
    • Can be associated with hemolysis or bone marrow suppression
    • Most common form of mild anemia in childhood
  • Family history
    • Familial history of splenectomy and/or early cholecystectomy can be a clue for a previously undiagnosed hemolytic anemia.

Physical Exam


  • Rapid respiratory rate, decreased BP, weak pulses, slow capillary refill
    • Indications of uncompensated anemia and/or shock
  • Frontal bossing and prominence of the malar and maxillary bones
    • Extramedullary erythropoiesis
  • Enlarged spleen
    • Hemolytic anemias, malignancy, infection
  • Glossitis
    • Vitamin B12 deficiency
    • Iron deficiency
  • Scleral icterus or jaundice
    • May indicate hemolysis
  • Systolic flow murmur
    • Anemia
  • Bruits
    • May indicate vascular malformations
  • Petechiae and bruising
    • May indicate an associated thrombocytopenia, coagulopathy, or vasculitis
  • Dysmorphic features
    • Diamond-Blackfan and Fanconi anemia are associated with other congenital defects, including thumb abnormalities, short stature, and congenital heart disease.

Diagnostic Tests & Interpretation


Lab
  • CBC with red cell indices
    • Establishes the diagnosis of anemia, distinguishes by size: normocytic, macrocytic, microcytic
  • Reticulocyte count
    • Distinguishes between decreased production and increased destruction of red cells
  • Coombs test and antibody screen
    • Identifies immune-mediated red cell destruction
    • Can have false positives and negatives
  • Peripheral blood smear
    • Specific morphologic findings can be diagnostic.
  • Iron studies: iron-binding capacity, serum iron, ferritin, transferrin
    • Iron deficiency anemia or anemia of chronic disease
  • Hemoglobin electrophoresis with quantification
    • Hemoglobinopathy
  • Lead studies: serum lead, free erythrocyte protoporphyrin
    • Plumbism
  • Stool guaiac
    • Occult blood loss
  • Osmotic fragility
    • Red cell membrane defects (spherocytosis)
    • Any spherocytic anemia may be positive.
  • Quantitative red cell " “enzyme assays
    • Inherited RBC enzyme deficiencies
  • Serum folate, RBC folate, and serum vitamin B12 levels
    • Deficiency

Diagnostic Procedures/Other
Bone marrow aspiration and biopsy: if malignancy or bone marrow failure syndrome suspected ‚  

Differential Diagnosis


  • Congenital
    • Hemoglobinopathies: sickle cell syndromes, thalassemia syndromes, other unstable hemoglobins
    • Erythrocyte membrane defects: hereditary spherocytosis, elliptocytosis, stomatocytosis, pyropoikilocytosis, infantile pyknocytosis
    • Erythrocyte enzyme defects: G6PD deficiency, pyruvate kinase deficiency
    • Diamond-Blackfan anemia: congenital pure red cell aplasia (rare)
    • Fanconi anemia: constellation of varied cytopenias, multiple congenital anomalies, abnormal bone marrow chromosomal fragility
  • Infectious
    • Septic shock
    • Can get mild anemia after mild infections in childhood (anemia of inflammation)
    • Infection-related bone marrow suppression: parvovirus B19 infection
    • Infection-related hemolytic anemias: Epstein-Barr virus, influenza, coxsackievirus, varicella, cytomegalovirus, Escherichia coli, Pneumococcus species, Streptococcus species, Salmonella typhi, Mycoplasma species
  • Nutritional/toxic/drugs
    • Iron deficiency anemia: common cause of anemia in children, especially those <3 years of age and in female adolescents
    • Plumbism: anemia usually due to coexisting iron deficiency; very high lead levels associated with altered heme synthesis
    • Vitamin B12 and/or folate deficiency: results in a megaloblastic anemia
    • Medication-induced bone marrow suppression: chemotherapy; antibiotics, especially trimethoprim-sulfamethoxazole
    • Drug-related hemolytic anemia: antibiotics, antiepileptics, azathioprine, isoniazid, nonsteroidal anti-inflammatory drugs
  • Trauma
    • Acute blood loss
  • Tumor
    • Leukemia with bone marrow infiltration
    • Metastatic tumors with bone marrow infiltration
  • Genetic/metabolic
    • Metabolic derangements: severe electrolyte disturbance, pH disturbance, inborn errors
    • Shwachman-Diamond syndrome: marrow hypoplasia with associated pancreatic insufficiency and associated failure to thrive
  • Other:
    • Transient erythroblastopenia of childhood: acquired pure RBC aplasia
    • Aplastic anemia: bone marrow failure syndrome with at least 2 of the 3 blood cell lines eventually affected
    • Systemic diseases: anemia of chronic disease, chronic renal disease, uremia
    • Hypothyroidism
    • Sideroblastic anemia: defective iron use within the developing erythrocytes
    • Autoimmune and isoimmune hemolytic anemias
    • Microangiopathic hemolytic anemias: thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), disseminated intravascular coagulation (DIC)
    • Mechanical destruction: vascular malformation, abnormal or prosthetic cardiac valves

Treatment


Initial Stabilization


  • Severe anemia of unclear etiology with hemodynamic instability
    • Transfuse with packed RBCs cautiously.
    • In an autoimmune hemolytic process, the child is at risk for a transfusion reaction, and there may be delay in obtaining cross-matched blood.
    • Obtain blood for diagnostic studies before transfusion if possible.
  • Circulatory failure without anemia
    • Requires intensive monitoring and access to critical care in an emergency department or intensive care unit
    • Fluid resuscitation and/or inotropic pressor support as needed
  • Acute blood loss
    • Treat circulatory failure as described.
    • Transfuse with packed RBCs, platelets, and fresh frozen plasma as needed.
  • Malignancies
    • Emergency care should be directed toward treatment of circulatory failure and possible associated infection and then to rapid diagnosis and treatment of the malignancy.
    • Consultation with an oncologist should be sought as soon as possible.

General Measures


  • Treat underlying cause.
  • Consider packed RBC transfusion if in extremis or severe anemia and low likelihood of recovery in near future.
  • Consider emergent plasmapheresis if with microangiopathic hemolytic anemia.
  • Consider immunosuppressive medications (corticosteroids, intravenous immunoglobulin (IVIG) if with autoimmune hemolytic anemia.
  • Iron deficiency anemia
    • Elemental iron

Medication


Elemental iron for patients with iron deficiency ‚  
  • 4 " “6 mg/kg/24 h PO divided b.i.d. " “t.i.d.
  • Absorbed best with acidic drinks, including orange juice; dairy products decrease absorption.
  • Reticulocyte should improve 72 hours after starting iron therapy; the hemoglobin may take a week to rise.
  • Iron should be continued for at least 3 months to replenish iron stores.

Ongoing Care


Issues for Referral


  • Severe or unexplained anemia
  • Anemias other than dietary iron deficiency or thalassemia trait
  • Recurrent iron deficiency
    • May suggest ongoing bleeding or iron malabsorption
  • All bone marrow failure or infiltrative processes

Additional Reading


  • Baker ‚  RD, Greer ‚  FR, Committee on Nutrition, American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics.  2010;126(5):1040 " “1050. ‚  [View Abstract]
  • Glader ‚  BE. Hemolytic anemia in children. Clin Lab Med.  1999;19(1):87 " “111. ‚  [View Abstract]
  • Graham ‚  EA. The changing face of anemia in infancy. Pediatr Rev.  1994;15(5):175 " “183. ‚  [View Abstract]
  • Monzon ‚  CM, Beaver ‚  D, Dillon ‚  TD. Evaluation of erythrocyte disorders with mean corpuscular volume (MCV) and red cell distribution width (RDW). Clin Pediatr.  1987;26(12):632 " “638. ‚  [View Abstract]
  • Segal ‚  G, Hirsh ‚  M, Feig ‚  S. Managing anemia in pediatric office practice: part 2. Pediatr Rev.  2002;23(4):111 " “122. ‚  [View Abstract]
  • Sills ‚  RH. Indications for bone marrow examination. Pediatr Rev.  1995;16(6):226 " “228. ‚  [View Abstract]

Codes


ICD09


  • 782.61 Pallor

ICD10


  • R23.1 Pallor

SNOMED


  • 162738007 On examination - color pale (finding)
Copyright © 2016 - 2017
Doctor123.org | Disclaimer